Last updated: 2026-10-15 18:00:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Regencell Bioscience Holdings Limited (RGC) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $10.51, with a market capitalization of $4.06B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.51 to $69.00. This page covers its latest market performance, valuation, price trends and company information.
$4.06B | |
$7.98 | |
$83.60 | |
$0.08 | |
$8.11 | |
1.39M | |
196.15K | |
-- | |
$69.00 | |
$4.51 | |
-- | |
-- |
Regencell Bioscience Holdings Limited (RGC) is currently trading at $10.51 as of 2026-10-15 17:44:32, up 29.57% ($2.40) from the previous close of $8.11
During today's regular trading session, RGC has traded between $0.08 and $83.60, with a trading volume of 1.39M shares. The current price is near the lower end of today's range.
Over the past seven days, Regencell Bioscience Holdings Limited (RGC) moved from $7.35 to $10.51, representing a gain of 42.97% ($3.16).
The stock traded between $6.82 and $11.08 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 303.56 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 9.3%
RGC is currently trading at $10.51, placing it 9.3% of the way from its 52-week low of $4.51 to its 52-week high of $69.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates.
| Employees | 10 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Regencell Bioscience Holdings Limited (RGC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.